EN DE
Watch Marex Group plc Ordinary Shares for free: we tell you when fair value or trend changes.
Data-driven stock valuation

Marex Group plc (MRX) fair value: what the stock is really worth

As of Nov 6, 2026: fair value (intrinsic value) of Marex Group plc stock $130, price $66.18, upside +96.3%, quality 62 out of 100. Rating: strongly undervalued. Calculated from audited financials with 13 of our 26 valuation models and 37 quality factors, updated daily.

  1. Keep an eye on it?Free in your watchlist: 5 stocks without an account, 10 with one Yes, for free

Financial Services US · Home United Kingdom · ISIN BMG5T40M1045

MG Marex Group plc logo Broad data Nov 6, 2026

Marex Group plc

MRX · US
Meets all rules: undervalued, solid quality, uptrend

The stock costs 49% less than our calculation considers fair.

Fair value $129.92 · Strongly undervalued (49%)
Quality 62/100
Healthy Growth (revenue 5y +36.8 %/yr in USD)
Solidly profitable · 12.2% net margin (TTM)
1.1% dividend yield · Low payout
Positive coverage
Broad data
Last quarter vs. a year ago: revenue +32%, profit +105%.
Mixed vs. peers (7/14)
Moderate moat 60/100 · thin data
Insiders sold $13.7M (6M)
Watch Marex Group plc Ordinary Shares for free: we tell you when fair value or trend changes. Watch for free

What runs behind every stock

26 valuation models 8 families, DCF to NCAV 37 quality factors margins, balance sheet, cashflow, debt 6 AI factors moat, what no ratio measures 2,000+ data points verified, per stock, median

69 individual criteria per stock, every one traceable See the method →

Price vs Fair Value

$78.27 $18.05 Fair Value $129.92 Apr 2024 Nov 2026

White line = price, green steps = our fair value per fiscal year. As of Nov 6, 2026.

How to read this chart

30‑month range $18.05 – $78.27 · fair‑value band $26.71 – $182.32 · the $66.18 price screens below the $129.92 fair value. Green steps = our fair value per fiscal year (point-in-time, no hindsight). As of Nov 6, 2026.

Follow Marex Group plc Ordinary Shares in your weekly email

Every Wednesday you see whether Marex Group plc Ordinary Shares is on track or worth a review, plus price against fair value. Free, up to 3 stocks.

We send you a confirmation link. Unsubscribe with one click.

Which stocks are undervalued right now? Check free Discover now →

Company profile

Marex Group plc, a financial services platform company, provides liquidity, market access, and infrastructure services to clients in the commodity and financial markets in the United Kingdom, the United States, and internationally.

Show moreShow less

It operates through Clearing, Agency and Execution, Market Making, and Hedging and Investment Solutions segments.

The company offers execution and clearing services in metals, agricultural products, energy and fixed income, financial securities, digital assets, and equity futures and options; liquidity, execution, and risk management solutions to financial markets.

It also provides liquidity to clients in the OTC energy markets; market data, analytics, and market commentary; energy services, including gas, power, environmental, and crude oil markets; and market-making services across commodities markets, such as metals, agricultural products, and energy markets.

In addition, the company offers OTC traded hedging and customized OTC derivatives solutions; and risk management solutions across a spectrum of markets, including agriculture, currency, and interest rate markets for trading houses, producers and consumers, and banks and distributors.

Further, it engages in the structured notes business, which allows investors to build structured notes across asset classes, including commodities, equities, foreign exchange, and fixed-income products for private banks, independent asset managers, pension funds, and corporates; and a portfolio of structured Notes, including auto-callable, fixed, stability, and credit-linked notes.

Additionally, the company offers technology platforms, including Neon, a trading, risk, and data platform; and Agile, a commodity broking platform. Marex Group plc was incorporated in 2005 and is based in London, the United Kingdom.

Stock analysis

Marex Group plc (MRX) currently trades at $66.18, while our model-based Fair Value estimate is $129.92, implying the stock looks roughly 49% undervalued today.

Show more

Valuation

Bull case: the Growth DCF group reads highest at a median of $358.98 per share, and 7 of the 13 models we run sit above the $66.18 price.

Bear case: the Dividend Discount group reads lowest at $14.71, and 6 of the 13 models stay below the price. Data coverage for this calculation is high.

Scenario range: $26.71 (bear) to $182.32 (bull), the price of $66.18 sits inside it. Bear and bull are the same models on cautious and optimistic assumptions, a range, not a price target.

Quality & growth

The Quality Score stands at 62/100 (solid quality), in the Financial Services sector.

Healthy Growth: Revenue growth appears healthy and is supported by profitability and cash-flow quality.

Marex Group plc Ordinary Shares reported revenue of $3.6B in FY2025 versus $852M in FY2021, a compound +43.7%/yr. Reported net income was $308M in FY2025, compounding +52.8%/yr from FY2021.

Key figures

Market cap $5.0B Mid · P/E ratio 13.1 · P/S ratio 1.44 · EPS (TTM) $4.95 · Dividend yield 1.1% · Net margin 12.2% · Return on equity 26.2% · Return on assets (EBIT) 2.7% (5-year average).

Competitive moat

Our AI-assisted moat analysis scores the competitive advantage at 60 out of 100 (low confidence).

What moves the price

The share trades about 15% below its 52-week high and 110% above its 52-week low, currently above its 200-day average.

For context, the median of 10 Financial Services peers we cover trades at −11% fair-value upside, at 96%, MRX screens cheaper than that median.

Fair Value models

Bear $26.71 Fair Value $129.92 Bull $182.32
Price $66.18 · Upside +96.3%
Capped: our models arrive at a very high value here. We deliberately show a more cautious Fair Value.
Model ⓘEach model values the company its own way (discounted cash flow, earnings, assets, dividends). The fair value above starts from their evidence-weighted blend, not from a single model. In cyclical trough or peak years, after dilution or a stock split it is adjusted afterwards, so it can sit above or below the models. Based on fiscal year 2025 figures (about 10 months old). Earnings retained since then ($3.59 per share) are deliberately not added. Bear ⓘBear = the cautious scenario: the same model computed with conservative anchors (lower growth, margins and valuation multiples). Together with Bull it frames a plausible valuation range, not a price target.BaseBull ⓘBull = the optimistic scenario: the same model computed with favourable anchors (higher growth, margins and valuation multiples). Together with Bear it frames a plausible valuation range, not a price target. If a model's bull case is above four times its base value, the table shows that limit with a > sign (like the overall Bull above): beyond it no assumption holds. Coverage ⓘCoverage = how well-backed THIS model's estimate is for this stock (0–100): how complete and reliable its input data are, and how well the model fits the company. The final Fair Value is an evidence-weighted blend, so better-evidenced models count more. Green ≥70, amber 50–69, grey below 50.
Best data coverage
Growth DCF $254.75 $475.92 $941.50 73
Owner Earnings $252.07 $566.56 $1,255 70
5Y P/E Exit $115.71 $190.66 $284.86 69
All 13 models by family
DCF Models
Owner Earnings $252.07 $566.56 $1,255 70
5Y P/E Exit $115.71 $190.66 $284.86 69
10Y P/E Exit $160.43 $264.65 $417.37 62
Earnings-Based
Graham-Dodd $29.14 $203.19 $285.14 63
Lynch FV $89.05 $127.21 $165.38 61
Dividend Discount
Gordon GGM $7.41 $16.16 $27.14 65
DDM Multi-Stage $7.41 $13.25 $16.84 66
Multiples
P/E Multiple $41.78 $55.70 $69.63 63
P/B Multiple $13.55 $18.07 $22.59 55
Asset-Based
NCAV (Graham) $6.45 $8.65 $12.91 54
Growth DCF
Growth DCF $254.75 $475.92 $941.50 73
Rev-Margin DCF $148.42 $242.03 $428.46 69
Economic Profit
Residual Income $29.40 $43.97 $99.57 69

Open the full fair value analysis →

Quality Score breakdown

Overall quality 62/100

It rates the business: profits, how they develop, real cash, balance sheet, investing and share count.

Profitability 33
How much profit the company makes from its sales and capital
Quality Growth 75
Are margins and returns getting better?
Cashflow 86
Do the profits arrive as real cash?
Financial strength 61
Debt, balance sheet and risk of trouble
Investment 33
Does it invest with discipline instead of growing at any price?
Low Volatility 66
How calm the share price moves, does not count
Price momentum 74
Price momentum of the last 3 to 12 months, does not count
Near the 52-week high 87
Distance to the 52-week high, does not count
New shares 77
Buys back shares or issues new ones?

Open the full quality analysis →

Insider trades

In the last 6 months, 5 officers or directors sold shares worth $13.7M and none bought.

  • SalePaolo TonucciOfficer7× since Apr 13, 2026: 116,666 shares, avg. $62.57$7.3MOct 12, 202610b5-1 plan
  • SaleSimon Van Den BornPresident4× since Apr 1, 2026: 57,072 shares, avg. $60.20$3.4MOct 12, 202610b5-1 plan
  • SaleRob IrvinChief Financial Officer, Director3,700 shares at $70.96$262,559Aug 14, 2026
  • SaleIan T LowittChief Executive Officer, Director2× since Jun 12, 2026: 74,285 shares, avg. $63.38$4.7MJul 13, 202610b5-1 plan
  • SaleThomas TexierGroup Head of Clearing3× since Apr 1, 2026: 30,426 shares, avg. $48.51$1.5MJun 1, 202610b5-1 plan

Plus 23 other filings such as grants, option exercises or tax withholding. They are not market purchases or sales.

Sales are often planned (taxes, diversification, 10b5-1 plans). Purchases with their own money are seen as the stronger sign. For information only: not part of the quality score or Fair Value.

Source: SEC Form 4, as of Nov 6, 2026. All filings at the SEC ↗

Revenue & earnings trend

Growth Quality ⓘGrowth is valuable only when reinvestment earns attractive returns (Aswath Damodaran): sustainable growth depends on return on capital, reinvestment and efficiency. Basis: total company revenue over the periods shown on the cards (3Y/5Y/all years), not per share, so a merger can show up as a growth jump; per-share earnings growth is in the value-creation card. 100/100
Revenue growth appears healthy and is supported by profitability and cash-flow quality.
Revenue growth 1 year
+25.4%
Revenue growth 3 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+45.6%
Revenue growth 5 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+36.8%
Start year 2020 (pandemic). Over 10 years: +26.5% a year
Revenue growth 12 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+21.3%
What shareholders gained per year (last 5 years) (mathematically smoothed) ⓘWhat the business itself delivers per year: earnings growth per share plus the dividend yield. This is what you get IF the market keeps valuing the stock the same way: it contains no assumption about the market changing its mind. Computed per share, so buybacks count and a merger does not pass as growth. For a company that pays no dividend it is pure earnings growth per share. Period: earnings growth per share as CAGR over the last 5 reported fiscal years (annual statements), plus the current dividend yield. The start value is the median of the three years around the start, so a single crisis year (a pandemic or a write-down) does not distort the rate. Smoothed = median of all growth paths between the years of the window (trend line on the logarithm of earnings per share): a single extreme year cannot distort the rate. The reported figure stays in the tooltip.
+47.4%
Earnings growth per share plus dividend.
Earnings per share, growth per year+46.3%
Dividend (yield on the price)1.1%
Pace: 5 vs 10 years ⓘTwo data points, not a trend model: earnings growth per share over the last 5 fiscal years against the last 10. Labelled "steady" when both rates are within 3 percentage points of each other, otherwise picking up or flattening. Shown only when ten years of history exist.41.1% vs 30.0%, picking up
Profit margin 2019 to 2025 ⓘOperating margin then vs now, from reported annual statements. A falling margin after a boom year is the classic peak-earnings signal: the growth rate then leans on an inflated base.2% → 32%
2025 sits 128% above its own trend. The rate follows the median trend of the last 5 years, not that single year.
Pace: the 5-year rate starts in 2020 (pandemic)

Watch MRX, get fair value alerts →

Earlier news

News mood ⓘNews mood, the average tone of recent news (94 articles), rated against how stocks are usually covered. 🚀 Hype = unusually upbeat · 🙂 Positive = above average · 😐 Neutral = typical · 🙁 Negative = below average · 😨 Very negative = unusually downbeat. It reflects the tone of coverage, not our valuation. Positive
Recent news coverage is more positive than average.
Note from the team Oct 17, 2026
AI conclusion: Marex's diversified platform in clearing, execution and hedging across commodities and financial markets forms its core strength, while thin evidence of durable advantages and high debt relative to equity mark the central weakness.
Main risk: High total debt relative to equity threatens the company's financial flexibility and could constrain funding for its clearing and market-making operations.
Marex operates a diversified platform that delivers clearing, execution, market making and hedging services across commodities and financial markets to thousands of clients. The recent board chair transition brings in a former CME CFO with extensive M&A experience precisely as the firm rolls out new digital asset indices and solutions. Will this leadership change tilt the business toward faster consolidation or help it deepen its role as a neutral liquidity provider in volatile markets?
Join the discussion →

Compare Marex Group plc Ordinary Shares with another stock

Price, fair value, quality and upside side by side.

Free, no sign-up

Peer GroupⓘHow this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.Capital Markets · 384 stocks

Beats the industry median on 7/14 measures
A mixed picture versus its industry peers.
Valuation
Quality Score 62 · Above median
Fair Value upside +96.3% · Top 25%
Profitability
Return on equity (12 months) 26.2% · Top 25%
Return on assets 0.9% · Bottom 25%
Net margin (12 months) 12.2% · Below median
Operating margin (12 months) 17.2% · Below median
Growth and dividend
Revenue growth (quarter YoY) 32.1% · Above median
Dividend yield (12 months) 1.1% · Below median
Balance sheet
Debt / equity 1.84× · Highest 25%

Valuation Multiplesvs Capital Markets median · lower = cheaper

P/E (12 months) 13.1× · Pricier than median
P/B 3.96× · Priciest 25%
P/S (12 months) 1.44× · Cheapest 25%
Price / free cash flow (fiscal year) 7.7× · Cheaper than median
EV/EBITDA 0.8× · Cheapest 25%

Strength profile in five axes (Snowflake)

VALUEFUTUREPASTHEALTHDIVIDEND
This stock
VALUEFUTUREPASTHEALTHDIVIDEND
Sector peers
VALUE (fair-value potential)100 · sector 43
FUTURE (revenue growth)100 · sector 67
PAST (return on equity)100 · sector 38
HEALTH (low debt)–
DIVIDEND (yield)23 · sector 47

HEALTH: for banks, insurers and similar financial firms borrowed money is part of the business, so we do not rate debt here.

Context: sector, industry, market

Values & ESG

Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.

None of the checked exposures detected

Similar stocks

10 more Capital Markets stocks, each showing price versus our Fair Value estimate.

Stock Price Fair Value vs Fair Value Compare
Morgan Stanley MS $181.44 $260.72 +44% vs MRX
The Charles Schwab Corporation SCHW $91.49 $117.60 +29% vs MRX
Guotai Haitong Securities Co 601211 ¥16.46 ¥18.02 +9% vs MRX
Nomura Holdings NMR $9.42 $10.20 +8% vs MRX
The Goldman Sachs Group GS $865.82 $766.86 −11% vs MRX
CITIC Securities Company 600030 ¥25.72 ¥20.42 −21% vs MRX
Robinhood Markets, Inc HOOD $80.91 $47.60 −41% vs MRX
Macquarie Group MQG A$248.86 A$123.84 −50% vs MRX
East Money Information Co 300059 ¥18.78 ¥6.72 −64% vs MRX
Interactive Brokers Group IBKR $75.82 $17.48 −77% vs MRX

Explore undervalued stocks

More undervalued Financial Services stocks →

All undervalued stocks TechnologyFinancial ServicesHealthcareConsumer CyclicalConsumer DefensiveCommunication ServicesIndustrialsEnergyBasic MaterialsReal EstateUtilities Deeply Undervalued StocksUndervalued High-Quality StocksUndervalued Blue-Chip StocksUndervalued Small-Cap StocksUndervalued Dividend StocksUndervalued 52-Week Low Stocks

Try a ready-made strategy

Pick a strategy and jump into the live analysis with that exact screen applied.

🥇 Backtested Best 🏆 Big Names 💎 Quality on Sale 🚀 Profitable Growth 🧊 Quality Compounders 💵 Dividend Stars 📈 Strong Momentum 📉 Fallen Angels ⚖️ Deeply Undervalued 🔍 Small-Cap Gems 🏰 Moat at a Fair Price 💼 Insider Buying 🎩 Buffett-Style Quality 📚 Peter Lynch GARP 🧮 Greenblatt Magic Formula 🛡️ Graham Defensive

Discover tools

Stock screenerFilter by region, size and sector Compare toolTwo stocks side by side Evidence & backtest34 years, failed companies included Financial calculatorsDCF, Graham, PEG and more
Run the numbers yourself: free valuation calculators
DCF CalculatorP/E Ratio CalculatorPEG Ratio CalculatorGraham NumberPeter Lynch FormulaDDM CalculatorIntrinsic ValueIntrinsic vs Extrinsic ValueP/E Ratio by Sector
For bloggers & editors: embed code + live data

For bloggers, editors and developers: paste this into your site or blog (a “Custom HTML” block in WordPress), it shows the current fair value and links back here. Free, plain HTML, and welcome. Full data streams (CSV/JSON) at /developers.

Marex Group plc Ordinary Shares: fair value per Fair Value Calculator

Cite: Fair Value Calculator (2026). "Marex Group plc Ordinary Shares Fair Value". https://www.fairvalue-calculator.com/stock/MRX

Frequently asked questions

Is Marex Group plc (MRX) overvalued or undervalued?
As of Nov 6, 2026, our model estimates a fair value of $129.92 versus a price of $66.18, about +96% upside (undervalued).
What is the fair value of MRX?
Our model-based fair value for Marex Group plc is $129.92 (as of Nov 6, 2026), built from audited fundamentals. The current price: $66.18.
What is the quality score of MRX?
Marex Group plc has a Quality Score of 62/100. It measures business quality (profitability, growth, cash flow, balance-sheet strength, investment discipline, share issuance). Market factors such as price momentum and volatility do not enter the number; they are shown separately in the detail view.
What is the price target for Marex Group plc (MRX)?
Our model-based price target is the fair value of $129.92 (as of Nov 6, 2026) from 13 valuation models. Cautious scenario $26.71, optimistic scenario $182.32. It is a calculation from audited fundamentals, not an analyst target.
What is the Marex Group plc Ordinary Shares stock forecast for 2026?
Our models put fair value at $129.92, about +96% upside versus a price of $66.18 (undervalued). Cautious scenario $26.71, optimistic scenario $182.32. The calculation is refreshed regularly with new filings.
What is the revenue of Marex Group plc (MRX)?
Marex Group plc reported trailing-twelve-month revenue of about $3.5B (latest available figure, as of Nov 6, 2026).
Does Marex Group plc Ordinary Shares pay a dividend?
Marex Group plc currently shows a dividend yield of 1.13% relative to its recent price (as of Nov 6, 2026).
How much is the dividend of Marex Group plc (MRX) and when is the ex-dividend date?
Marex Group plc pays a dividend of $0.75 per share a year, a dividend yield of 1.1%. The last ex-dividend date was Aug 24, 2026. The payout ratio is 15.2% of earnings. Our assessment: Low payout. A low payout ratio: the dividend takes at most 60 % of earnings. Whether free cash flow covers it as well, we cannot see for this company.
What is the intrinsic value of Marex Group plc (MRX)?
Intrinsic value and fair value mean the same thing: what the business is worth on its numbers, independent of the share price. For Marex Group plc it is $129.92 per share (as of Nov 6, 2026), against a price of $66.18. It is the blended result of 13 valuation models in 7 families (DCF Models, Earnings-Based, Dividend Discount, Multiples, Asset-Based, Growth DCF, Economic Profit).
Is Marex Group plc Ordinary Shares stock overvalued or undervalued in 2026?
As of Nov 6, 2026, MRX trades below its calculated fair value: price $66.18, fair value $129.92, a gap of about +96% (undervalued). The calculation is refreshed with each new quarterly report, so the verdict can change during the year.
Is fair value the same as the market price of MRX?
No. The price is what the market pays today ($66.18); the fair value is what the company's own numbers justify ($129.92). For Marex Group plc the two are $63.74 per share apart. That gap is exactly why we show both numbers side by side.
How much is Marex Group plc Ordinary Shares worth?
The market values Marex Group plc at about $5.0B (market capitalisation, as of Nov 6, 2026). Per share that is $66.18; our models calculate a fair value of $129.92 per share.
What do the bullish and bearish scenarios say about MRX?
Our models span a range for Marex Group plc: cautious scenario $26.71, base $129.92, optimistic $182.32 per share (as of Nov 6, 2026, price $66.18). The range comes from different growth and margin assumptions, not from analyst opinions.
What is the P/E ratio of MRX?
Marex Group plc trades at a price-to-earnings ratio of 13.1 (as of Nov 6, 2026). A P/E on its own says little: it compares the price with ONE year of profit, while our fair value of $129.92 is built from several models across several years. Other multiples: P/B 4.0, P/S 1.4, EV/EBITDA 0.8.
How solid is the balance sheet of Marex Group plc (MRX)?
Balance-sheet figures for Marex Group plc (as of Nov 6, 2026): return on equity 26.2%, debt of 1.84 per unit of equity. They feed the Quality Score of 62/100, which measures business quality independently of the share price.
How far is MRX from its 52-week high?
Marex Group plc trades at $66.18, about 15% below its 52-week high of $78.27 and 110% above the low of $31.52 (as of Nov 6, 2026). Distance from the high says nothing about value: that is what the fair value of $129.92 is for.
Which stocks are comparable to Marex Group plc Ordinary Shares?
From the same area (Financial Services) we also value Morgan Stanley, The Goldman Sachs Group, The Charles Schwab Corporation, Interactive Brokers Group, among others. Each of them has its own fair-value calculation on this site using the same models, so the comparison is like for like.
Is Marex Group plc Ordinary Shares stock attractive at the current price?
The data as of Nov 6, 2026: price $66.18, calculated fair value $129.92 (+96%), Quality Score 62/100, from 13 models. Whether that fits your horizon and risk tolerance is your call. We provide the calculation, not investment advice.
How is the fair value of MRX calculated?
We run Marex Group plc through 13 models from 7 families: DCF Models, Earnings-Based, Dividend Discount, Multiples, Asset-Based, Growth DCF, Economic Profit. Every model gets the same audited fundamentals; the fair value of $129.92 builds on their evidence-weighted average, with the spread shown as a cautious and an optimistic scenario.
Is it still worth investing in stocks now?
The global stock market currently sits 13.0% above its aggregate fair value. Marex Group plc currently trades 49% below its own fair value, and the market average says nothing about that. An expensive market is no reason to stay out and no reason to buy everything at once: keep a broad savings plan running, buy single stocks only with money you can do without, and hold part of your money liquid while the market is high. The full picture including sectors is on is it worth investing now.
What is the share price of Marex Group plc (MRX)?
The closing price on Nov 6, 2026 was $66.18. Our model-based fair value is $129.92, about +96% upside (undervalued). We carry closing prices from our data provider, not a live tick.
What should I pay attention to with Marex Group plc Ordinary Shares right now?
The model range is unusually wide ($26.71 to $182.32). The outcome hinges heavily on assumptions, so read the point estimate with caution. Solid quality (62/100) at a price below fair value, the discount is the argument here, not the business quality. For a financial, book-value and earnings-based methods matter more than a cash-flow DCF, which fits banks and insurers poorly.
Where does the earnings growth of Marex Group plc (MRX) come from?
Earnings per share at Marex Group plc grew +28.4 % a year from 2014 to 2025. Broken into its drivers: revenue per share +24.0 %, EBIT margin +19.3 %, tax rate −1.4 %, residual (interest, one-offs) −12.0 %. The four rates multiply to the earnings growth rate, they do not add up. Start and end are three-year averages so a single exceptional year does not distort the result.

Key figures of Marex Group plc

How large is the market capitalisation of Marex Group plc (MRX)?
The market capitalisation of Marex Group plc is $5.0B. The stock-market value of the whole company: share price times number of shares. It is what the market asks for the entire business today.
What is the P/S ratio of Marex Group plc (MRX)?
The price-to-sales ratio of Marex Group plc is 1.44 (last twelve months). Price to sales: market value relative to yearly revenue. Useful when profit is thin or distorted.
What are the earnings per share of Marex Group plc (MRX)?
Earnings per share at Marex Group plc are $4.95 (price ÷ EPS = P/E 13.1). Earnings per share over the last twelve months: total profit spread across every single share.
What is the dividend yield of Marex Group plc (MRX)?
The dividend yield of Marex Group plc is 1.1% (payout 15.2%). Yearly dividend relative to the share price. 3% pays 3 per 100 invested. Below: how much of profit is used for it.
What is the net margin of Marex Group plc (MRX)?
The net margin of Marex Group plc is 12.2% (last twelve months). How much of every unit of revenue ends up as profit. 10% means 10 cents of profit per dollar of sales.
What is the return on equity of Marex Group plc (MRX)?
The return on equity (ROE) of Marex Group plc is 26.2% (last twelve months). Profit relative to shareholders' equity, how efficiently the company works with its owners' money.
What is the EBIT return on assets of Marex Group plc (MRX)?
On an EBIT basis the return on assets of Marex Group plc is 2.7% (avg 5y). Operating profit (EBIT) relative to everything the company owns, as a multi-year average. It describes the business model rather than one good or bad year.
What is the operating margin of Marex Group plc (MRX)?
The operating margin of Marex Group plc is 17.2% (last twelve months). Profit from the core business (before interest and taxes) relative to revenue.
How fast is revenue growing at Marex Group plc (MRX)?
Revenue at Marex Group plc is growing +32.1% versus a year earlier (3y avg +45.6%). How much revenue grew versus a year earlier (YoY). The 3-year average next to it puts the single year in context.
How fast are earnings growing at Marex Group plc (MRX)?
Earnings per share at Marex Group plc are growing +105% versus a year earlier. How much earnings per share grew versus a year earlier.
How much free cash flow does Marex Group plc (MRX) generate?
The free cash flow of Marex Group plc is $654M (fiscal year 2025). The cash truly left after running and investing in the business, this is what pays dividends and buybacks.
How much net debt does Marex Group plc (MRX) carry?
The net debt of Marex Group plc is $3.8B (fiscal year 2025, ≈ 5.8 yrs of FCF). Debt minus cash on hand. The note shows how many years of free cash flow could in theory pay it off.
Free · no account needed

Watch Marex Group plc Ordinary Shares in the live analysis

One click puts Marex Group plc Ordinary Shares on your watchlist: fair value and trend at a glance, plus comparison, the diversification check and the 27,000+ stock screener.

Watch for free →

Zero risk: nothing is ever charged. Your watchlist is yours, with or without an account.